PUBLISHER: The Business Research Company | PRODUCT CODE: 1939234
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939234
Antimicrobial resistance (AMR) surveillance involves the systematic monitoring and tracking of antimicrobial-resistant microorganisms to detect emerging resistance patterns, guide public health interventions, and inform treatment strategies for infections caused by resistant bacteria, viruses, and fungi.
The primary solutions in AMR surveillance include diagnostic kits, diagnostic systems, surveillance software, and services. Diagnostic kits are pre-packaged tools that enable healthcare professionals to rapidly identify antimicrobial-resistant infections in patients. These solutions are applied in clinical diagnostics, public health surveillance, and other areas, serving end users such as hospitals and clinics, research and academic institutes, and other healthcare facilities.
Tariffs are impacting the antimicrobial resistance surveillance market by increasing costs of sequencing systems, diagnostic kits, and data analytics infrastructure. Genomic and AI-based surveillance solutions are most affected, particularly in regions dependent on imported laboratory equipment. Conversely, tariffs have supported regional lab capacity building and software-driven surveillance adoption.
The antimicrobial resistance surveillance market research report is one of a series of new reports from The Business Research Company that provides antimicrobial resistance surveillance market statistics, including antimicrobial resistance surveillance industry global market size, regional shares, competitors with a antimicrobial resistance surveillance market share, detailed antimicrobial resistance surveillance market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial resistance surveillance industry. This antimicrobial resistance surveillance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The antimicrobial resistance surveillance market size has grown strongly in recent years. It will grow from $7.3 billion in 2025 to $7.91 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rise in drug-resistant infections, hospital infection control initiatives, public health surveillance programs, laboratory testing expansion, antibiotic misuse concerns.
The antimicrobial resistance surveillance market size is expected to see strong growth in the next few years. It will grow to $10.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to global AMR monitoring initiatives, AI-driven predictive surveillance, cloud-based data sharing, genomic surveillance growth, policy-driven reporting mandates. Major trends in the forecast period include real-time resistance pattern monitoring, whole genome sequencing surveillance, AI-based resistance analytics, integrated public health databases, hospital-wide AMR tracking systems.
The increasing prevalence of infectious diseases is expected to drive the growth of the antimicrobial resistance surveillance market. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites and can spread directly or indirectly between individuals. Factors such as climate change, urbanization, and global travel contribute to the rising prevalence of these diseases by facilitating pathogen transmission and increasing human exposure to new microbes. Antimicrobial resistance surveillance plays a crucial role in tracking the spread of resistant pathogens, guiding effective treatment strategies, and shaping public health policies to combat infectious diseases. For example, in February 2024, a report by the UK Health Security Agency revealed a 10.7% increase in tuberculosis (TB) cases in England, with 4,850 cases reported in 2023 compared to 4,380 in 2022. As a result, the increasing prevalence of infectious diseases is fueling the expansion of the antimicrobial resistance surveillance market.
Leading companies in the industry are focusing on innovative technologies, such as advanced diagnostic tools, to improve efficiency, enhance accuracy, reduce costs, and provide better patient outcomes. A diagnostic tool encompasses any device, instrument, software, or methodology used to detect, identify, or assess the presence of a condition, disease, or malfunction. For instance, in June 2023, Sysmex Astrego AB, a Sweden-based manufacturer of diagnostic products, launched the PA-100 AST Point-of-Care Testing System. This system enables rapid and precise detection of antimicrobial resistance at the point of care, significantly reducing the time required for results compared to conventional laboratory methods, which can take several days. By delivering results in just 30 minutes, it empowers clinicians to make timely and informed decisions regarding infection treatment, minimizing reliance on broad-spectrum antibiotics and aiding efforts to curb antimicrobial resistance.
In January 2024, BioMerieux S.A., a France-based biotechnology company, acquired LUMED for an undisclosed amount. This acquisition is aimed at enhancing BioMerieux's capabilities in combating antimicrobial resistance and strengthening its portfolio, particularly by offering digital tools to support antibiotic stewardship. LUMED Inc., an Italy-based company, specializes in healthcare and medical data analysis, with a focus on antimicrobial resistance surveillance.
Major companies operating in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Cepheid Inc., Accelerate Diagnostics Inc., Liofilchem S.r.l., Luminex Corporation, Sysmex Corporation, Werfen, OpGen Inc., Illumina Inc., Oxford Nanopore Technologies plc, Himedia Laboratories Pvt. Ltd., Alifax S.r.l.
North America was the largest region in the antimicrobial resistance surveillance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the antimicrobial resistance surveillance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The antimicrobial resistance (AMR) surveillance market consists of revenues earned by entities by providing services such as diagnostic testing services, surveillance data collection and analysis, antimicrobial stewardship programs, and infection control and prevention services. The market value includes the value of related goods sold by the service provider or included within the service offering. The antimicrobial resistance (AMR) surveillance market also includes sales of diagnostic equipment and tools, antimicrobial agents, laboratory instruments, and software and data analytics platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Antimicrobial Resistance Surveillance Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses antimicrobial resistance surveillance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for antimicrobial resistance surveillance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antimicrobial resistance surveillance market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.